image
Coherus BioSciences, Inc. CHRS
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 0.8215
5.08 %
$ 95.2 M
Market Cap
3.29
P/E
Price Target Average
812.96%
Revenue Forecast Estimate
--5.03%
EBIT Estimate
5.55%
Net Income Estimate
--38.49%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Coherus BioSciences, Inc.
image
Wall Street analysts predict an average 1-year price target for CHRS of $7.5 , with forecasts ranging from a low of $6 to a high of $11 .
CHRS Lowest Price Target Wall Street Target
6 USD 630.37%
CHRS Average Price Target Wall Street Target
7.5 USD 812.96%
CHRS Highest Price Target Wall Street Target
11 USD 1239.01%
Price
Max Price Target
Min Price Target
Average Price Target
121210108866442200May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart CHRS

image
$500.0m$500.0m$450.0m$450.0m$400.0m$400.0m$350.0m$350.0m$300.0m$300.0m$250.0m$250.0m$200.0m$200.0m$150.0m$150.0m$100.0m$100.0m$50.0m$50.0m$0.0$0.02015201520162016201720172019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CHRS

image
$1.0b$1.0b$0.0$0.0($1.0b)($1.0b)($2.0b)($2.0b)($3.0b)($3.0b)($4.0b)($4.0b)($5.0b)($5.0b)($6.0b)($6.0b)2015201520162016201720172019201920202020202120212022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CHRS

image
$1.0b$1.0b$0.0$0.0($1.0b)($1.0b)($2.0b)($2.0b)($3.0b)($3.0b)($4.0b)($4.0b)($5.0b)($5.0b)($6.0b)($6.0b)($7.0b)($7.0b)2015201520162016201720172019201920202020202120212022202220232023202420242025202520262026202720272028202820292029